Posted in | News | Materials Analysis

Quality Control of Radiopharmaceuticals

Monitoring the stannous tin (Sn(II)) content in technetium-99m (99mTc) radiopharmaceuticals is essential for quality control. Differential pulse polarography is a straightforward, interference-free, and sensitive technique for this analysis mentioned by the IAEA (International Atomic Energy Agency) Technical Report Series No 466 as analysis method. Metrohm Application Note AN-V-219 describes the analysis for a cold kit for preparation of sodium pertechnetate (99mTc) injection.

Image Credit: Metrohm Middle East FZC

Technetium-99m (99mTc) radiopharmaceuticals are widely used as imaging agent in diagnostic procedures. The Technetium-99m is usually obtained as pertechnetate. For further usage, the Tc(VII) is usually reduced to the desired oxidation state, which is required to form the nontoxic, stable organic complex, used in diagnostic imagining. Stannous tin (Sn(II)) is the typically applied reducing agent.

As too low amount of Sn(II) can result in inadequate reduction of the pertechnetate, a minimal Sn(II) content is required. Furthermore, too high Sn(II) contents can have a detrimental effect on the active organic complex.

Compared to iodometric titration, polarography is insensitive to other reducing agents, ensuring an interference-free analysis of stannous tin in the mg/L levels. To learn more about the method download our free Application Note AN-V-219 on this analysis.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Metrohm Middle East FZC. (2023, January 27). Quality Control of Radiopharmaceuticals. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=60756.

  • MLA

    Metrohm Middle East FZC. "Quality Control of Radiopharmaceuticals". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=60756>.

  • Chicago

    Metrohm Middle East FZC. "Quality Control of Radiopharmaceuticals". AZoM. https://www.azom.com/news.aspx?newsID=60756. (accessed November 21, 2024).

  • Harvard

    Metrohm Middle East FZC. 2023. Quality Control of Radiopharmaceuticals. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=60756.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.